There are many different types of hair growth disorder, including Androgenetic Alopecia, Telogen Effluvium, Alopecia Areata, Traction Alopecia, Trichotillomania, Cicatricial Alopecia and diffuse hair loss, which are caused by a range of internal/external factors, such as stress, hormones, diet, health conditions, medicine, hairstyling and genetics, among others. However, regardless of the hair-loss type or cause, the Hair Growth Cycle is almost always affected. This is because the major contributor to increased hair shedding and weaker re-growth is often a disruption to the normal, healthy Hair Growth Cycle.
The Hair Growth Cycle becomes ‘disrupted’ when internal/external factors de-stabilise the well-balanced system regulating hair growth within the follicles. A major aspect of Hair Growth Cycle disruption is a disturbance to the influential function provided by the critical proteoglycan proteins.
Effectively treating a disrupted Hair Growth Cycle requires providing the correct formulation of ingredients directly to the hair follicle, which is best achieved with regular supplementation to form a continuous, baseline treatment comprising essential bioavailable ingredients. Marilex® is a fractionated fish extract with specific lectican proteoglycans, which are the essential proteoglycan proteins influencing the normal function of the hair follicle. Marilex® is based on more than 25 years of research and development, and is the proprietary ingredient of Pharma Medico found exclusively in Nourkrin® products. The latest clinical study, published in a peer-reviewed clinical journal in 2015, concluded that, “supplementation with this bioavailable ingredient can revitalise dysfunctional hair follicles, and is beneficial to use as a continuous, baseline treatment for all types of hair loss”.